Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Cilofexor

Copy Product Info
😃Good
Catalog No. T7436Cas No. 1418274-28-8

Cilofexor inhibits binding of a synthetic peptide, Cilofexor is a farnesoid X receptor (FXR) agonist.

Cilofexor

Cilofexor

Copy Product Info
😃Good
Purity: 99.86%
Catalog No. T7436Cas No. 1418274-28-8
Cilofexor inhibits binding of a synthetic peptide, Cilofexor is a farnesoid X receptor (FXR) agonist.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$46In StockIn Stock
2 mg$70In StockIn Stock
5 mg$126In StockIn Stock
10 mg$198In StockIn Stock
25 mg$396In StockIn Stock
50 mg$596In StockIn Stock
100 mg$787-In Stock
200 mg$1,070-In Stock
1 mL x 10 mM (in DMSO)$161In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.86%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Cilofexor AI Summary
Cilofexor exhibits agonist activity at the FXR (Farnesoid X Receptor) with EC50 values of 15.0 nM and 41.0 nM in different assays. It has demonstrated variable effects on cell viability across different cell types: promoting growth in HEK293T cells with growth rates ranging from 0.54 to 1.0 and displaying a potential inhibitory effect on human fibroblast cells with a growth rate of -0.03 in one assay. Moreover, Cilofexor affects the thermal stability of various protein domains as evidenced by Thermal Shift Assay results, increasing stability for certain domains (e.g., start/stop: M1-K294 and P449-E759) and decreasing stability for others (e.g., start/stop: M1-L298 and N44-E168). These observations indicate that the bioactivity of Cilofexor is both cell-type and protein-domain dependent, suggesting potential modulatory effects on cellular growth and protein function..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Cilofexor inhibits binding of a synthetic peptide, Cilofexor is a farnesoid X receptor (FXR) agonist.
Targets&IC50
FXR:43 nM (EC50)
Chemical Properties
Molecular Weight586.85
FormulaC28H22Cl3N3O5
Cas No.1418274-28-8
SmilesOC(=O)c1ccnc(c1)N1CC(O)(C1)c1ccc(OCc2c(onc2-c2c(Cl)cccc2Cl)C2CC2)cc1Cl
Relative Density.1.538 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 166.7 mg/mL (284.06 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (6.82 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.7040 mL8.5201 mL17.0401 mL85.2006 mL
5 mM0.3408 mL1.7040 mL3.4080 mL17.0401 mL
10 mM0.1704 mL0.8520 mL1.7040 mL8.5201 mL
20 mM0.0852 mL0.4260 mL0.8520 mL4.2600 mL
50 mM0.0341 mL0.1704 mL0.3408 mL1.7040 mL
100 mM0.0170 mL0.0852 mL0.1704 mL0.8520 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Cilofexor | purchase Cilofexor | Cilofexor cost | order Cilofexor | Cilofexor chemical structure | Cilofexor formula | Cilofexor molecular weight